Rachel B. Issaka

Works at

Sources: reporter.nih.gov

Grants and prizes

  • National Cancer Institute

    R37, PROACT: Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel Interventions, R37CA295618, 2025–2030, 27 Jul 2026

  • National Cancer Institute

    K08, Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach, K08CA241296, 2019–2025, 27 Jul 2023

Sources: reporter.nih.gov